Global Swab and Viral Transport Medium Market Size, Share, Growth Analysis Report - Forecast 2034

Swab and Viral Transport Medium Market Size And Forecast

The global swab and viral transport medium market size was worth around USD 9.43 Billion in 2024 and is predicted to grow to around USD 12.67 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 3% between 2025 and 2034. The report analyzes the global swab and viral transport medium market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the swab and viral transport medium industry.

Request Free Sample

Swab and Viral Transport Medium Market: Overview

The accuracy of a medical diagnosis starts with two key components: the right method for collecting the right amount of a viral sample and careful storage of that material as it is transferred to a laboratory for analysis. Viral transport media is a solution that ensures the safe transfer of viral samples to a laboratory for analysis. Major players in the market are focused on developing improved testing techniques such as molecular assay studies and rapid antigen testing, which will help cater to demand over time. Moreover, the development and advancement in the diagnosis of these viruses require transport medium and microbiological culture swab to preserve and later analyze the viral growth. Recent developments in the swab and viral transport medium and increased awareness regarding swab and viral transport medium diagnosis are the major factors driving the growth of the global swab and viral transport medium market. Lastly, unfavorable rules and regulatory scenarios might limit the growth of the swab and viral transport medium market.

COVID-19 Impact:

The COVID-19 outbreak benefits the swab and viral transport medium market. The swab and viral transport medium market have recently experienced a significant increase in affordability and flexibility of swab, and viral transport medium diagnosis was also one of the major reasons behind its large-scale adoption during the pandemic.

Request Free Sample

Key Insights

• As per the analysis shared by our research analyst, the global swab and viral transport medium market is estimated to grow annually at a CAGR of around 3% over the forecast period (2025-2034).
• Regarding revenue, the global swab and viral transport medium market size was valued at around USD 9.43 Billion in 2024 and is projected to reach USD 12.67 Billion by 2034.
• The swab and viral transport medium market is projected to grow at a significant rate due to rising infectious disease prevalence, increased COVID-19 testing demand, advancements in diagnostic technologies, and growing emphasis on early disease detection.
• Based on Type, the Swab Transport Medium segment is expected to lead the global market.
• On the basis of Application, the Clinical segment is growing at a high rate and will continue to dominate the global market.
• Based on the Collection Method, the Nasopharyngeal Swab segment is projected to swipe the largest market share.
• By Preservative, the Viral Inactivating Agents (VIA) segment is expected to dominate the global market.
• In terms of Packaging, the Single-Use Tubes segment is anticipated to command the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Swab and Viral Transport Medium Market: Growth Drivers

Scalability and affordability of swab and viral transport medium to drive market growth

Swab and viral transport medium diagnosis kits can be manufactured and supplied based on demand and market dynamics. It is easier to scale the production of swabs and viral transport medium than its substitutes. At the same time, the cost of swab and viral transport medium is less compared to its counterparts due to various government support initiatives and recent developments in the swab and viral transport medium diagnosis field. This is likely to fuel the growth of the global swab and viral transport medium market over the forecast period.

Swab and Viral Transport Medium Market: Restraint

Uncertain regulatory framework to hinder the market growth

The adoption and growth of the swab and viral transport medium diagnosis are limited by unfavorable regulatory scenarios, which further limit the expansion of regional players in the market. Certain regulations make it difficult to get approval for these diagnoses and thus further limit the market growth.

Swab and Viral Transport Medium Market: Opportunity

Non-government organizations and government initiatives present market opportunities

Various non-governmental organizations (NGOs) and governments executed different initiatives to create awareness and manufacture swabs and viral transport medium in underdeveloped and developing nations, which is expected to act as an opportunity for key manufacturers in the global swab and viral transport medium market. For instance, in May 2020, the Sree Chitra Tribunal Institute for Medical Sciences and Technology (SCTIMST), a part of the DSTGovernment of India, developed two types of swabs and viral transport medium from oral and nasal for COVID-19 testing. Thus, similar developments and activities by organizations might create opportunities for future swab and viral transport medium manufacturers.

Swab and Viral Transport Medium Market: Challenge

Uncertain and unpredictable nature of infections and seasonal influenza

The uncertain and unpredictable nature of infections, viruses, and influenza has led to the worldwide adoption of a conservative approach by various swab and viral transport medium diagnosis test manufacturing companies to lower supply even during the Covid-19 pandemic.

Swab and Viral Transport Medium Market: Segmentation

The global swab and viral transport medium market are segregated based on type, end-user, application, and region.

Based on type, the market is divided into swab type and transport medium. Among these, the swab type segment dominates the market, accounting for more than 58 percent of global sales in 2021. The swab segment is more cost-effective, and its scalability is also high. With advancements like double-ended flocked swabs, kits with integrated vials, and other innovations, swabs have substantially improved over time. This has helped the market for swabs and viral transmission mediums grow. Swab usage increased the likelihood of finding each respiratory virus. As a result, other types of swabs for other infections, such as nasal, nasopharyngeal, and throat, will continue to offer a considerable earning potential and have the largest market share.

Based on application, the market is classified into viral infection diagnosis and others. Over the forecast period, the viral infection diagnosis market is expected to develop faster. Swab and transport medium testing is the most suitable diagnosis method for viral infections. Swabs and viral transport medium can be used to properly detect these viruses, which is necessary for diagnosing or treating these disorders. As a result, applications account for the largest market share.

Based on end-user, the market is classified into hospitals & clinics, microbiology laboratories, diagnostic laboratories, and others. The hospitals & clinics segment dominates the market, accounting for more than 42 percent of global revenue in 2021. This is mostly due to the high number of patients seeking treatment for viral infections who visit hospitals and ASCs, increasing the demand for swabs and viral transport mediums for accurate diagnosis.

Swab and Viral Transport Medium Market: Report Scope

Recent Developments

• August 2021: Cardinal Health strategically collaborated with Abbott and Quidel to provide rapid o, over-the-counter.
• June 2018: McKesson Corporation acquired Medical Specialties distribution to expand its specialty and services offered.

Report Scope:

Swab and Viral Transport Medium Market: Regional Landscape

North America dominated the swab and viral transport medium market in 2024

North America dominates the global swab and viral transport medium market and accounted for most of the global revenue in 2024. At the same time, the U.S. accounted for more than 94% of the North American swab and viral transport medium market. The major reason behind the growth of the swab and viral transport medium market is the enhancement in the availability of new diagnostic drugs and tests such as OTC (over-the-counter) products in retail shops and pharmacies in the region to support the American population to sustain against the COVID-19. Moreover, better manufacturing capability and efficiency of swab and viral transport medium and a rise in production levels are further promoting the growth of the swab and viral medium transport market in the region.

Swab and Viral Transport Medium Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the swab and viral transport medium market on a global and regional basis.

The global swab and viral transport medium market is dominated by players like:

• Virocult B.V.
• HiMedia Laboratories Pvt. Ltd.
• EKF Diagnostics
• MWE GmbH
• Sarstedt AG Co. KG
• Medical Packaging Solutions Inc.
• 3M
• Copan Diagnostics Inc.
• Qiagen
• Medical Wire Equipment Co. Ltd.
• Becton Dickinson and Company
• Promega Corporation
• Puritan Medical Products Company LLC
• Longhorn Vaccines Diagnostics LLC
• Thermo Fisher Scientific Inc.

The global swab and viral transport medium market is segmented as follows;

By Type

• Swab Transport Medium
• Viral Transport Medium

By Application

• Clinical
• Laboratory
• Research

By Collection Method

• Nasopharyngeal Swab
• Oropharyngeal Swab
• Nasal Swab
• Saliva Collection
• Blood Collection

By Preservative

• Viral Inactivating Agents (VIA)
• Non-Viral Inactivating Agents (NVIA)
• Other Preservatives

By Packaging

• Single-Use Tubes
• Multi-Use Containers
• Other Packaging Formats

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America